brain Logo
DE
  • 61

    Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2025
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2025
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • ESG-Strategie auf einen Blick
    • Environment
    • Social Responsibility
    • Corporate Management
    • Sustainability Reporting
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

28.02.2024
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
Finance
Show Article
17.01.2024
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
Corporate Finance
Show Article
20.11.2023
Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy
Technology
Show Article
28.09.2023
BRAIN Biotech AG´s Akribion Genomics team wins first prize in the “BioRiver Boost!” startup competition
Technology
Show Article
14.09.2023
BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
Technology
Show Article
12.09.2023
Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
Technology
Show Article
30.08.2023
BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
Finance
Show Article
28.06.2023
BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
Technology
Show Article
19.06.2023
Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
Corporate
Show Article
  • 1
  • 3
  • 4
  • 5
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2026 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings